NMPA

RSS

China's regulatory authority approves phase II trials of F-351

July 3, 2014

Chinese fast track designation granted to epilepsy drug DP-VPA

June 11, 2014

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical obtains Chinese clinical trial clearance

May 22, 2014

Sihuan Pharmaceutical's application for clinical trial approval for pirotinib accepted in China

Oct. 14, 2013

Lee's Pharmaceutical submits CTA to expand the APEX study to China

Aug. 29, 2013

Lee's Pharmaceutical files to perform pivotal trial of gimatecan for ovarian cancer in China

Aug. 8, 2013

Takeda receives marketing authorization in China for Nesina

Aug. 2, 2013

Beijing Drug Administration accepts Sinovac's filing for EV71 vaccine candidate

May 31, 2013

Sihuan Pharmaceutical cleared to conduct study of DPP IV inhibitor in China

Feb. 26, 2013

Revlimid approved in China, gets priority review for new indication in U.S.

Feb. 12, 2013